https://www.selleckchem.com/pr....oducts/eflornithine-
c antispasmodic drugs. Surveillance No consensus exists regarding the frequency of clinical follow-up visits, but reevaluation once or twice yearly to identify and treat new complications is recommended. Agents/circumstances to avoid Dantrolene, as it can induce irreversible weakness, adversely affecting mobility. Genetic counseling ATL1-HSP is almost exclusively inherited in an autosomal dominant manner. More than 95% of individuals diagnosed with SPG3A have an affected parent; the proportion of individuals w
Like
Comment
Share
